Farallon discloses multi-million share holdings in InflaRx
Rhea-AI Filing Summary
InflaRx N.V. 13G group filing: multiple Farallon entities and associated individuals report shared voting and dispositive power over disclosed Ordinary Shares (CUSIP N44821101). The filing lists per-entity share holdings and percentages (for example, Farallon Partners, L.L.C. 7,307,250 shares, 5%; certain Farallon individual reporting persons 7,500,000 shares, 5.1%). The Reporting Persons state the Shares are held directly by the Farallon Funds, file pursuant to Section 240.13d-1(c), and include a joint acquisition statement; the Reporting Persons neither disclaim nor affirm the existence of a group and also include express disclaimers of beneficial ownership by certain general partner and individual entities.
Positive
- None.
Negative
- None.
Insights
Large institutional holdings disclosed across Farallon funds and named managers.
The filing itemizes share counts and voting/dispositive power for multiple Farallon funds and affiliated persons, showing single-entity stakes ranging from six-figure positions to multi-million share positions with single-digit percentages of the class. These are reported as shared voting/dispositive power.
Implications depend on holder decisions and any future amendments; subsequent filings may disclose changes in holdings or group status.
Key Figures
Key Terms
Section 240.13d-1(c) regulatory
Joint Acquisition Statement regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the InflaRx (IFRX) Schedule 13G filing disclose?
Who are the Reporting Persons named in the IFRX filing?
What voting or dispositive power is reported in the filing?
Does the filing state a group relationship among Reporting Persons?
What security class and identifier are covered by this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.